A search for evidence of somatic mutations in the NF1 gene

Journal of Medical Genetics

Volumn 37, Issue 1, 2000, Pages 44-49

  John, Alison M ^a   Ruggieri, Martino ^b   Ferner, Ros ^c   Upadhyaya, Meena ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CATANIA   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Neurofibromatosis; NF1 gene; Somatic mutations

Indexed keywords

DNA;

ALLELE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; GENE INACTIVATION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0034014385     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.37.1.44     Document Type: Article

References (39)

1. Barker D, Wright E, Nguyen K, et al. Gene for Von Recklinghausen's neurofibromatosis in the pericentric region of chromosome 17. Science 1987; 236:1100-2.
2. Seizinger BR, Rouleau GA, Ozelius Z, et al. Genetic linkage of von Recklinghausen's neurofibromatosis to the nerve growth factor receptor gene. Cell 1987;49:589-94.
3. Viskochil D, Buchberg AM, Xu G, et al. Deletions and translocations interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990;62:187-92.
4. Wallace MR, Marchuk DA, Anderson LB, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three patients. Science 1990;249:182-6.
5. Xu G, O'Connell P, Viskochil D, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990; 62:599-608.
6. Ferner RE. Medical complications in NF1. In: Upadhyaya M, Cooper DN, eds. Neurofibromatosis type 1: from genotype to phenotype. Oxford: BIOS Publishers, 1998.
7. Korf BR, Huson SM, Needle M, et al. Report on the working group on neurofibroma. USA: The National Neurofibromatosis Foundation, 1997:4-27.
8. Seizinger B. NF1: a prevalent cause of tumourigenesis in human cancers? Nat Genet 1993;3:97-9.
9. Knudson AG. Mutation and cancer: statistical study of neuroblastoma. Proc Natl Acad Sci USA 1971;68:820-3.
10. Colman SD, Williams CA, Wallace MR. Benign neurofibromas in type I neurofibromatosis (NF1) show somatic deletion of the NF1 gene. Nat Genet 1995;11:90-2.
11. Serra E, Puig S, Otero D, et al. Confirmation of the double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 1997;61:512-19.
12. Daschner K, Assum G, Eisenbath I, et al. Clonal origin of tumour cells in a plexiform neurofibroma with LOH in intron 38 and in dermal neurofibromas without LOH of the NF1 gene. Biochem Biophys Res Commun 1997;234:346-50.
13. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbour Laboratory Press, 1989.
14. U Y, O'Connell P, Briedenbach HH, et al Genomic organisation of the neurofibromatosis 1 gene (NF1). Genomics 1995;25:9-18.
15. Abernathy CR, Rasmussen SA, Stalker HJ, et al. NF1 mutation analysis using a combined heteroduplex/SSCP approach. Hum Mutat 1997;9:548-54.
16. Shannon KM, O'Connell P, Martin GA, et al. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 1997;330:570-601.
17. Hoff M, Nakamura Y, Holm T, et al. Isolation and mapping of a polymorphic DNA sequence pHHH202 on chromosome 17 (D17S33), Nucleic Acids Res 1988;16:781.
18. Hoffmeyer S, Assum G. An Rsa1 polymorphism in the transcribed region of the neurofibromatosis (NF1) gene. Hum Genet 1994;93:481-2.
19. Regnier V, Danglot G, Nguyen VC, Bernheim A, A Tsp509I variant in exon 13 of the neurofibromatosis type 1 (NF1) gene allows the identification of both alleles at the mRNA level. Hum Genet 1995;96:131-2.
20. Xu G, Nelson L, O'Connell P, White R. An Alu polymorphism intragenic to the neurofibromatosis type 1 gene (NF1). Nucleic Acids Res 1991;19:3764.
21. Lazaro C, Gaona A, Estivill X. Two CA/GT repeat polymorphisms in intron 27 of the neurofibromatosis type 1 (NF1) gene. Hum Genet 1994;93:351-2.
22. Lazaro C, Gaona A, Xu G, Weiss R, Estivill X. A highly informative CA/GT repeat polymorphism in intron 38 of the neurofibromatosis type 1 (NF1) gene. Hum Genet 1993;92:429-30.
23. Abernathy C, Coleman SD, Wallace MR. A PCR-based test for a polymorphism within the human NF1 gene. Clin Genet 1994;45:313.
24. Purandare SM, Lanyon WG, Connor JM. Characterisation of inherited and sporadic mutations in neurofibromatosis type-1 Hum Mol Genet 1994;3:1109-15.
25. Fain PR, Barker D, Golgar D, et al. Genetic analysis of NF1: identification of close flanking markers on chromosome 17. Genomics 1988;1:340-5.
26. Cowley GS, Murthy AE, Parry DM, et al Genetic variation in the 3′ untranslated region of the neurofibromatosis 1 gene: application to unequal allelic expression. Som Cell Mol Genet 1998;24:107-19.
27. Weber JI, Kwitek AE, May PE, Wallace MR, Collins FS, Ledbetter DH. Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucleic Acids Res 1990;18: 4640.
28. Upadhyaya M, Ruggieri M, Maynard J, et al. Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay. Hum Genet 1998;102:591-7.
29. Maynard J, Upadhyaya M. High throughput screening for the detection of unknown mutations: improved productivity using heteroduplex analysis. Biotechniques 1998;25:648-51.
30. NNFF International NF1 Genetic Analysis Consortium. www. clam.com/nf/nf1gene/
31. Upadhyaya M, Cooper DN. The mutational spectrum in neurofibromatosis 1 and its underlying mechanisms in neurofibromatosis type 1. In: Upadhyaya M, Cooper DN, eds. Neurofibromatosis type 1: from genotype to phenotype. Oxford: BIOS Publishers, 1998.
32. Cotton RGH. Mutation detection. Oxford: Oxford University Press, 1997.
33. Legius E, Marchuck DA, Collins FS, Glover TW. Somatic deletion of the neurofibromatosis type I gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 1993;3:122-6.
34. Sawada S, Florell S, Purandare SM, Ota M, Stephens K, Viskochil D. Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet 1996; 14:110-12.
35. Maynard J, Krawczak M, Upadhyaya M. Characterisation and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene. Hum Genet 1997;99: 674-6.
36. Gonzalez-Zulueta M, Ponder CM, Yang AS, et al. Methylation of the 5′CpG island of the p16/CDKN2 tumour suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995;55: 4531-5.
37. Herman JG, Latif F, Wong Y, et al. Silencing of the VHL tumour suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 1994;91:9700-4.
38. Herman G, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525-30.
39. Sakai T, Taguchida J, Ohtani J, et al. Allele-specific hypermethylation of the retinoblastoma tumour suppressor gene. Am J Hum Genet 1991;48:880-8.